李淑华, 王成效, 汤喜红, 高霞, 吴春珠, 谢范迪, 陈宇. 上海市某城区114岁人群麻疹疫苗抗体水平消减模型建立与分析[J]. 上海预防医学, 2021, 33(5): 410-413. DOI: 10.19428/j.cnki.sjpm.2021.19949
引用本文: 李淑华, 王成效, 汤喜红, 高霞, 吴春珠, 谢范迪, 陈宇. 上海市某城区114岁人群麻疹疫苗抗体水平消减模型建立与分析[J]. 上海预防医学, 2021, 33(5): 410-413. DOI: 10.19428/j.cnki.sjpm.2021.19949
LI Shu-hua, WANG Cheng-xiao, TANG Xi-hong, GAO Xia, WU Chun-zhu, XIE Fan-di, CHEN Yu. Attenuation of anti-measles antibody in the healthy population aged 1-14 years old in an urban district, Shanghai[J]. Shanghai Journal of Preventive Medicine, 2021, 33(5): 410-413. DOI: 10.19428/j.cnki.sjpm.2021.19949
Citation: LI Shu-hua, WANG Cheng-xiao, TANG Xi-hong, GAO Xia, WU Chun-zhu, XIE Fan-di, CHEN Yu. Attenuation of anti-measles antibody in the healthy population aged 1-14 years old in an urban district, Shanghai[J]. Shanghai Journal of Preventive Medicine, 2021, 33(5): 410-413. DOI: 10.19428/j.cnki.sjpm.2021.19949

上海市某城区114岁人群麻疹疫苗抗体水平消减模型建立与分析

Attenuation of anti-measles antibody in the healthy population aged 1-14 years old in an urban district, Shanghai

  • 摘要:
    目的 了解上海市1~14岁健康人群麻疹疫苗免疫水平情况及其消减趋势,预测成年人群发病风险,为针对性制定麻疹强化免疫策略提供依据。
    方法 采用横断面研究,在上海市某城区医院收集2016—2018年儿科门诊及住院病历中1~14岁上海市户籍健康人群血清,采用酶联免疫吸附实验(ELISA)检测麻疹IgG抗体浓度,并予以动态比较分析。
    结果 1~14岁健康人群血清麻疹抗体阳性率为95.29%,抗体保护率为61.86%,几何平均滴度(GMT)2.957 6(抗体水平为906.98 mIU/mL),男女之间抗体水平分布差异均无统计学意义(P>0.05)。在不同年龄组之间,抗体水平随着年龄增长呈下降趋势(P<0.05),10岁以后抗体水平下降较为明显,13~14岁时阳性率为87.41%,保护率仅为22.96%,GMT为2.667 1(抗体水平为464.62 mIU/mL)。根据抗体GMT水平随年龄消减的拟合模型 Y ̂ (回归) = 3.217-0.04XR2 =0.943,P<0.05),预测19~20岁时抗体水平保护率几乎为0、29~30岁时抗体水平阳性率几乎为0。
    结论 在几乎无麻疹自然感染的情况下,接种麻疹疫苗后,疫苗抗体浓度随着年龄的增长呈现直线下降的趋势,10岁以后下降较为明显,15岁以后处于较低的水平。为控制成年人口未来的麻疹发病,建议对10~15岁人群进行强化免疫,并将其列为麻疹防控工作的重点对象。

     

    Abstract:
    Objective To determine the level of anti-measles antibody in healthy population aged 1-14 years old in Shanghai, and project the risk of measles incidence in adult population in the future, which may provide evidence for enhancing the measles immunization strategy.
    Methods A cross-sectional study was conducted to collect the serum of healthy people aged 1-14 years old in an urban district hospital in Shanghai. Serum concentration of anti-measles IgG antibody was examined by enzyme-linked immunosorbent assay (ELISA) and dynamics of IgG antibody was compared.
    Results The prevalence of anti-measles antibody in healthy people aged 1-14 years old was determined to be 95.29%, and the antibody protection rate was 61.86%. There was no significant difference in the distribution of antibody between men and women (P>0.05). However, there was statistical difference in the distribution of antibody among different age groups (P<0.05), in which the antibody showed a decreasing trend with age, especially after the age of 10 years. The lowest prevalence of anti-measles antibody and protection rate were observed in the population aged 13-14 years old, which were 87.41% and 22.96%, respectively. The GMT was 2.667 1 (equal to the concentration of anti-measles IgG antibody being 464.62 mIU/mL). According to the fitting model Y ̂ =3.217-0.04XR2 =0.943,P<0.05), the antibody protection rate was projected to decrease to zero in the population aged 19-20 years old, whereas the anti-measles antibody was to zero in the population aged 29-30 years old .
    Conclusion As there is almost no natural infection of measles,the anti-measles antibody after measles vaccine immunization showed a linearly decreasing trend with age after measles immunization.It is recommended that people aged 10-15 years should be administered intensive immunization for prevention of adults measles,which could be incorporated into current measles immunization strategies.

     

/

返回文章
返回